Q2 2020 Holdings
Filed 2020-08-13 | 186 holdings | $262.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A/S(ASND) | ADR | 04351P101 | $164.2M | 1,109,874 | 62.6% |
| Coherus BioSciences(CHRS) | COMM | 19249H103 | $34.5M | 1,933,221 | 13.2% |
| Abbvie Inc(ABBV) | COMM | 00287Y109 | $24.7M | 251,959 | 9.4% |
| Akebia Therapeutics Inc(AKBA) | COMM | 00972D105 | $9.3M | 681,892 | 3.5% |
| Biomarin Pharmaceutical Inc(BMRN) | COMM | 09061G101 | $7.8M | 62,897 | 3.0% |
| Axsome Therapeutics Inc(AXSM) | COMM | 05464T104 | $7.2M | 86,978 | 2.7% |
| BioCryst Pharmaceuticals Inc(BCRX) | COMM | 09058V103 | $6.5M | 1,357,848 | 2.5% |
| Cytokinetics Inc(CYTK) | COMM | 23282W605 | $3.8M | 160,217 | 1.4% |
| Aclaris Therapeutics(ACRS) | COMM | 00461U105 | $3.1M | 1,911,573 | 1.2% |
| Karuna Therapeutics, Inc. | COMM | 48576A100 | $210.2K | 1,885,602 | 0.1% |
| Natera(NTRA) | COMM | 632307104 | $154.6K | 3,100,560 | 0.1% |
| Y-mAbs Therapeutics, Inc(YMABUSD) | COMM | 984241109 | $94.8K | 2,194,278 | 0.0% |
| Principia Biopharma(PRNB) | COMM | 74257L108 | $84.7K | 1,417,258 | 0.0% |
| Nextcure, Inc | COMM | 65343E108 | $57.3K | 2,671,856 | 0.0% |
| Amgen IncPut | COMM | 031162950 | $39.7K | 168,500 | 0.0% |
| United Therapeutics Corp(UTHR) | COMM | 91307C102 | $36.9K | 304,562 | 0.0% |
| Amarin | ADR | 023111206 | $36.0K | 5,208,305 | 0.0% |
| Merck & Co Inc(MRK) | COMM | 58933Y105 | $34.9K | 451,178 | 0.0% |
| Akouos, Inc | ADR | 00973J101 | $34.1K | 1,515,073 | 0.0% |
| Gilead Sciences Inc(GILD) | COMM | 375558103 | $31.0K | 403,494 | 0.0% |
| ObsEva SA | COMM | H5861P103 | $28.0K | 4,749,623 | 0.0% |
| Jazz Pharmaceuticals PLC(JAZZ) | COMM | G50871105 | $26.9K | 243,353 | 0.0% |
| Eli Lilly & Co(LLY) | COMM | 532457108 | $24.4K | 148,900 | 0.0% |
| PTC Therapeutics Inc(PTCT) | COMM | 69366J200 | $22.2K | 438,270 | 0.0% |
| Alnylam Pharmaceuticals IncCall | COMM | 02043Q907 | $22.2K | 150,000 | 0.0% |
| Galera Therapeutics, Inc(GRTX) | COMM | 36338D108 | $22.0K | 3,083,712 | 0.0% |
| Merus N.V. | COMM | N5749R100 | $21.1K | 1,311,039 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COMM | 00434H108 | $20.7K | 217,390 | 0.0% |
| Kiniksa Pharmaceuticals, Ltd | COMM CL A | G5269C101 | $20.6K | 809,803 | 0.0% |
| Spdr Ser TrPut | S&P Biotech | 78464A950 | $16.8K | 150,000 | 0.0% |
| Select Sector Spdr TrPut | SBI Healthcare | 81369Y959 | $15.0K | 150,000 | 0.0% |
| Horizon Therapeutics PLC | COMM | G46188101 | $14.1K | 252,958 | 0.0% |
| TG Therapeutics Inc(TGTX) | COMM | 88322Q108 | $13.6K | 696,390 | 0.0% |
| Insmed Inc(INSM) | COMM | 457669307 | $13.3K | 483,967 | 0.0% |
| Nucana Biomed Ltd | Ordinary Shares | GBOOBYWYV | $13.0K | 2,400,000 | 0.0% |
| Puma Biotechnology Inc(PBYI) | COMM | 74587V107 | $12.5K | 1,197,630 | 0.0% |
| Nucana Biomed Ltd | ADR | 67022C106 | $12.3K | 2,266,666 | 0.0% |
| Supernus Pharmaceuticals Inc(SUPN) | COMM | 868459108 | $11.4K | 478,329 | 0.0% |
| Zymeworks Inc | COMM | 98985W102 | $10.8K | 299,734 | 0.0% |
| MyoKardia Inc | COMM | 62857M105 | $10.8K | 111,810 | 0.0% |
| Mirum Pharmaceuticals Inc(MIRM) | COMM | 604749101 | $10.5K | 541,701 | 0.0% |
| iShares TrPut | Russell 2000 ETF | 464287955 | $10.0K | 70,000 | 0.0% |
| Kura Oncology Inc(KURA) | COMM | 50127T109 | $10.0K | 610,979 | 0.0% |
| Chiasma(CHMA) | COMM | 16706W102 | $8.8K | 1,630,221 | 0.0% |
| Kadmon Holdings Inc(KDMN) | COMM | 48283N106 | $7.8K | 1,530,864 | 0.0% |
| Invesco QQQ TrustPut | UNIT SER 1 | 46090E953 | $7.4K | 30,000 | 0.0% |
| Blueprint Medicines Corp(2L9) | COMM | 09627Y109 | $7.4K | 94,891 | 0.0% |
| Liquidia Technologies Inc(LQDA) | COMM | 53635D202 | $6.7K | 800,000 | 0.0% |
| Applied Genetic Technologies Corp(2GT) | COMM | 03820J100 | $6.3K | 1,145,254 | 0.0% |
| Constellation Pharmaceuticals Inc(CNST) | COMM | 210373106 | $6.2K | 207,087 | 0.0% |